Nifty
:
10588.65
Sensex
:
36012.93
36.95 (0.35%)
169.23 (0.47%)
Nifty
Sensex
:
:
10588.65
36012.93
36.95 (0.35%)
169.23 (0.47%)

Glaxosmithkline Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :
77/99

BSE: 500660 | NSE: GLAXO

NSE BSE
1466.25
02-Jul-2020
  • Open
  • High
  • Low
  • Previous Close
  •  1485.00
  •  1489.90
  •  1460.00
  •  1472.35
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  19355
  •  285.31
  •  1748.00
  •  962.65

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 24,854.41
  • 266.68
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 23,683.64
  • 1.36%
  • 13.65

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 75.00%
  • 0.60%
  • 10.97%
  • FII
  • DII
  • Others
  • 0.3%
  • 4.61%
  • 8.52%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 2.59
  • 3.94

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 6.56
  • 5.38

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -24.35
  • -35.71

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 58.25
  • 61.87
  • 62.59

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 12.04
  • 12.67
  • 11.12

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 32.60
  • 37.66
  • 36.81

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Jun 19
Jun 18
Var%
Net Sales
775.80
750.81
3.33%
778.59
825.35
-5.67%
882.02
816.31
8.05%
787.97
735.65
7.11%
Expenses
602.24
587.83
2.45%
654.20
688.20
-4.94%
688.01
651.28
5.64%
622.68
600.02
3.78%
EBITDA
173.56
162.98
6.49%
124.39
137.15
-9.30%
194.01
165.03
17.56%
165.29
135.63
21.87%
EBIDTM
22.37%
21.71%
15.98%
16.62%
22.00%
20.22%
20.98%
18.44%
Other Income
15.82
52.72
-69.99%
16.50
16.58
-0.48%
15.88
15.01
5.80%
30.81
18.01
71.07%
Interest
1.51
0.08
1,787.50%
2.98
0.05
5,860.00%
0.92
0.22
318.18%
0.93
0.20
365.00%
Depreciation
22.59
13.68
65.13%
18.33
12.04
52.24%
22.70
11.51
97.22%
19.06
11.36
67.78%
PBT
176.55
221.86
-20.42%
-634.32
170.48
-
587.41
156.52
275.29%
176.11
133.80
31.62%
Tax
38.48
75.05
-48.73%
26.84
56.81
-52.75%
84.66
55.69
52.02%
62.57
49.72
25.84%
PAT
138.07
146.81
-5.95%
-661.16
113.67
-
502.75
100.83
398.61%
113.54
84.08
35.04%
PATM
17.80%
19.55%
-84.92%
13.77%
57.00%
12.35%
14.41%
11.43%
EPS
8.15
8.67
-6.00%
-39.03
6.71
-
29.68
5.95
398.82%
6.70
4.96
35.08%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Dec 13
Dec 12
Dec 11
Dec 10
Net Sales
-
3,224.38
3,128.12
2,871.45
2,908.47
2,837.91
3,362.91
2,607.70
2,692.06
2,455.38
2,151.06
Net Sales Growth
-
3.08%
8.94%
-1.27%
2.49%
-15.61%
28.96%
-3.13%
9.64%
14.15%
 
Cost Of Goods Sold
-
1,307.87
1,358.03
1,241.31
1,397.75
1,324.90
1,327.66
1,171.68
1,100.57
923.50
785.73
Gross Profit
-
1,916.51
1,770.09
1,630.14
1,510.72
1,513.02
2,035.25
1,436.02
1,591.49
1,531.87
1,365.33
GP Margin
-
59.44%
56.59%
56.77%
51.94%
53.31%
60.52%
55.07%
59.12%
62.39%
63.47%
Total Expenditure
-
2,567.13
2,527.32
2,365.66
2,489.49
2,359.64
2,788.33
2,124.49
1,915.22
1,693.90
1,478.25
Power & Fuel Cost
-
33.36
27.94
26.44
27.82
25.97
31.17
23.85
22.50
26.70
26.75
% Of Sales
-
1.03%
0.89%
0.92%
0.96%
0.92%
0.93%
0.91%
0.84%
1.09%
1.24%
Employee Cost
-
628.55
537.20
523.40
483.01
443.37
493.02
362.05
295.52
278.36
234.53
% Of Sales
-
19.49%
17.17%
18.23%
16.61%
15.62%
14.66%
13.88%
10.98%
11.34%
10.90%
Manufacturing Exp.
-
110.63
115.55
110.55
108.26
118.09
367.24
127.78
113.62
111.44
67.51
% Of Sales
-
3.43%
3.69%
3.85%
3.72%
4.16%
10.92%
4.90%
4.22%
4.54%
3.14%
General & Admin Exp.
-
190.68
178.60
204.45
195.08
154.85
178.21
135.34
126.10
108.51
145.09
% Of Sales
-
5.91%
5.71%
7.12%
6.71%
5.46%
5.30%
5.19%
4.68%
4.42%
6.75%
Selling & Distn. Exp.
-
182.39
202.81
154.38
178.91
164.47
222.31
186.23
160.74
157.60
140.85
% Of Sales
-
5.66%
6.48%
5.38%
6.15%
5.80%
6.61%
7.14%
5.97%
6.42%
6.55%
Miscellaneous Exp.
-
113.66
107.20
105.12
98.67
127.99
168.72
117.55
96.17
87.78
140.85
% Of Sales
-
3.53%
3.43%
3.66%
3.39%
4.51%
5.02%
4.51%
3.57%
3.58%
3.36%
EBITDA
-
657.25
600.80
505.79
418.98
478.27
574.58
483.21
776.84
761.48
672.81
EBITDA Margin
-
20.38%
19.21%
17.61%
14.41%
16.85%
17.09%
18.53%
28.86%
31.01%
31.28%
Other Income
-
79.01
102.32
54.54
73.07
123.18
258.80
222.30
223.90
186.59
217.06
Interest
-
6.34
0.55
0.19
0.25
0.42
0.47
0.33
0.33
0.33
0.62
Depreciation
-
82.68
48.59
37.99
26.35
24.95
25.35
19.88
17.84
20.41
17.63
PBT
-
647.25
653.97
522.17
465.46
576.08
807.56
685.30
982.58
927.33
871.62
Tax
-
212.55
237.28
189.24
174.37
202.25
279.27
229.78
272.48
176.20
293.35
Tax Rate
-
69.52%
34.76%
35.05%
34.11%
34.97%
36.96%
32.30%
32.66%
29.13%
33.66%
PAT
-
93.20
445.39
350.73
336.81
376.14
476.41
481.67
561.88
428.59
578.27
PAT before Minority Interest
-
93.20
445.39
350.73
336.81
376.14
476.41
481.67
561.88
428.59
578.27
Minority Interest
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
-
2.89%
14.24%
12.21%
11.58%
13.25%
14.17%
18.47%
20.87%
17.46%
26.88%
PAT Growth
-
-79.07%
26.99%
4.13%
-10.46%
-21.05%
-1.09%
-14.28%
31.10%
-25.88%
 
EPS
-
5.50
26.29
20.70
19.88
22.20
28.12
28.43
33.17
25.30
34.14

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Dec 13
Dec 12
Dec 11
Dec 10
Shareholder's Funds
1,820.60
2,139.83
2,057.33
2,006.86
2,183.25
1,828.98
1,989.73
2,006.83
1,935.70
1,951.58
Share Capital
169.41
169.41
84.70
84.70
84.70
84.70
84.70
84.70
84.70
84.70
Total Reserves
1,651.20
1,970.42
1,972.63
1,922.15
2,098.55
1,744.28
1,905.03
1,922.13
1,851.00
1,866.88
Non-Current Liabilities
3,042.54
2,860.37
2,632.47
3,699.70
3,498.32
197.04
158.59
158.45
172.78
-51.43
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.02
0.18
0.58
0.99
1.60
2.63
3.61
4.14
4.59
5.16
Long Term Provisions
3,124.09
2,920.20
2,733.36
3,786.83
3,592.19
272.21
242.29
236.05
224.81
0.00
Current Liabilities
2,369.31
2,804.07
2,948.98
881.09
783.63
1,106.55
888.91
836.40
859.59
3,179.07
Trade Payables
357.59
405.81
505.86
278.93
327.74
308.04
285.63
237.37
200.58
334.36
Other Current Liabilities
228.46
802.71
842.35
390.47
202.82
130.09
84.13
86.82
67.25
12.60
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
1,783.27
1,595.54
1,600.77
211.69
253.08
668.42
519.15
512.21
591.77
2,832.12
Total Liabilities
7,232.45
7,804.27
7,638.78
6,587.65
6,465.20
3,132.57
3,037.23
3,001.68
2,968.07
5,079.22
Net Block
756.59
429.99
322.81
252.71
204.04
123.08
100.09
89.42
99.15
108.95
Gross Block
1,452.35
559.05
405.89
299.09
228.36
363.34
343.22
316.18
315.80
362.54
Accumulated Depreciation
695.76
129.06
83.08
46.38
24.32
240.26
243.13
226.76
216.65
253.59
Non Current Assets
4,112.52
4,445.06
4,103.26
4,752.54
4,087.05
545.58
413.30
355.01
363.01
235.57
Capital Work in Progress
120.12
1,002.64
922.90
605.46
267.67
115.22
61.86
43.79
16.19
8.72
Non Current Investment
1.49
1.69
1.84
5.40
6.04
0.06
0.06
10.06
54.98
117.90
Long Term Loans & Adv.
3,227.15
3,002.88
2,850.97
3,882.49
3,609.24
296.09
237.73
194.55
157.01
0.00
Other Non Current Assets
7.17
7.84
4.75
6.47
0.06
11.13
13.55
17.19
35.68
0.00
Current Assets
3,119.93
3,359.21
3,535.52
1,835.10
2,378.15
2,586.98
2,623.94
2,646.67
2,605.06
4,843.65
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
10.00
44.91
57.21
0.00
Inventories
483.03
486.49
500.18
425.80
525.87
375.58
346.97
285.15
333.44
285.55
Sundry Debtors
99.80
120.49
146.96
170.80
126.56
100.32
96.39
115.90
85.31
47.03
Cash & Bank
1,083.20
1,171.35
1,296.41
899.61
1,391.90
1,910.61
2,041.58
2,066.77
2,014.36
2,002.89
Other Current Assets
1,453.90
112.30
78.72
106.70
333.82
200.47
128.99
133.94
114.74
2,508.18
Short Term Loans & Adv.
1,405.32
1,468.58
1,513.25
232.20
310.58
112.04
71.19
58.18
50.12
2,454.34
Net Current Assets
750.62
555.14
586.54
954.01
1,594.52
1,480.43
1,735.03
1,810.27
1,745.46
1,664.58
Total Assets
7,232.45
7,804.27
7,638.78
6,587.64
6,465.20
3,132.56
3,037.24
3,001.68
2,968.07
5,079.22

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Dec 13
Dec 12
Dec 11
Dec 10
Cash From Operating Activity
490.50
399.38
472.80
234.37
138.90
337.64
281.31
313.59
335.37
479.36
PBT
647.25
653.97
522.17
465.46
576.08
807.56
685.30
982.58
927.33
871.62
Adjustment
13.17
-31.36
-12.17
-46.47
-96.01
-173.66
-156.37
-159.63
-139.38
-89.96
Changes in Working Capital
44.07
-4.19
164.56
-26.69
-124.41
-36.90
11.45
56.35
-73.09
12.66
Cash after chg. in Working capital
704.49
618.41
674.55
392.29
355.67
597.00
540.37
879.30
714.86
794.32
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-179.72
-204.34
-202.01
-160.59
-205.95
-252.43
-244.09
-318.38
-316.53
-313.89
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
-34.26
-14.69
0.25
2.67
-10.82
-6.93
0.00
0.00
0.00
0.00
Cash From Investing Activity
-56.84
-143.34
-104.19
300.64
499.02
180.01
188.98
-109.65
358.03
86.76
Net Fixed Assets
-10.78
-232.90
-424.24
-408.52
-61.62
-73.47
-45.11
-27.98
39.27
-16.58
Net Investments
0.20
23.26
3.56
0.64
-5.96
10.00
44.92
57.21
0.55
30.56
Others
-46.26
66.30
316.49
708.52
566.60
243.48
189.17
-138.88
318.21
72.78
Cash from Financing Activity
-427.62
-358.36
-306.63
-510.76
-638.33
-496.99
-494.14
-440.63
-394.81
-297.15
Net Cash Inflow / Outflow
6.03
-102.33
61.97
24.24
-0.42
20.66
-23.85
-236.69
298.59
268.97
Opening Cash & Equivalents
98.78
201.10
139.13
114.89
115.30
94.93
137.67
374.36
75.77
1,734.03
Closing Cash & Equivalent
104.81
98.78
201.10
139.13
114.89
115.59
113.82
137.67
374.36
2,003.01

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Dec 13
Dec 12
Dec 11
Dec 10
Book Value (Rs.)
107.47
126.31
121.44
118.46
128.88
107.96
117.45
118.46
114.26
115.20
ROA
1.24%
5.77%
4.93%
5.16%
7.84%
15.44%
15.95%
18.82%
10.65%
12.12%
ROE
4.71%
21.22%
17.26%
16.08%
18.75%
24.95%
24.10%
28.50%
22.05%
30.94%
ROCE
15.76%
32.54%
26.56%
24.39%
28.82%
39.53%
35.54%
42.24%
31.05%
46.54%
Fixed Asset Turnover
3.21
6.48
8.21
11.38
9.59
9.82
8.13
8.74
7.40
6.31
Receivable days
12.47
15.60
20.03
18.09
14.59
10.35
14.45
13.29
9.62
8.38
Inventory Days
54.88
57.56
58.36
57.89
57.97
38.01
43.02
40.86
45.01
45.13
Payable days
58.60
73.24
66.07
51.56
53.81
43.72
49.18
47.40
62.14
88.58
Cash Conversion Cycle
8.75
-0.07
12.32
24.42
18.75
4.64
8.28
6.75
-7.51
-35.07
Total Debt/Equity
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest Cover
49.26
1232.59
2856.45
2045.74
1373.88
1612.26
2146.51
2497.59
1848.25
1403.44

Annual Reports:

FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014
FY 2013
FY 2012
FY 2011
FY 2010

News Update:


  • GlaxoSmithKline Pharmaceuticals to discontinue manufacture, supply of Zinetac tablets
    21st May 2020, 14:26 PM

    The company will in due course request cancellation of the marketing authorization(s) associated with Zinetac Tablets

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.